First human test for potential psoriasis drug begins
Knowledge-focused
Ongoing
This is an early safety study to see how the body handles a single dose of an experimental drug called SHR-1139. It involves 24 healthy volunteers and will check for side effects and measure how long the drug stays in the body. The goal is to gather basic safety information befor…
Phase: PHASE1 • Sponsor: Atridia Pty Ltd. • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:41 UTC